Renal Cell Carcinoma Clinical Trials Database - Free Access to 293 Studies
Access comprehensive clinical trial information for Renal Cell Carcinoma through Pure Global AI's free database. This collection includes 293 clinical trials across multiple phases including N/A, Phase 2, Early Phase 1. Currently, 48 trials are actively recruiting participants.
Research for Renal Cell Carcinoma is being conducted in United States of America, China, Canada and 7+ other countries. Leading sponsors include Pfizer and Bristol-Myers Squibb. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)
A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004)
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma
Delving Into Participation Trends in Renal Cell Carcinoma Studies
Moesin Expression in Clear Cell Renal Cell Carcinoma
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment
Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)
Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy
68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma
Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study
A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma
Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma
Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma
Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)
Pure Global AI provides free access to 293 clinical trials studying Renal Cell Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Pfizer, Bristol-Myers Squibb, M.D. Anderson Cancer Center, among others.